Oncorus, Inc. (ONCR) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 85 transactions totaling $36.8M, demonstrating a bullish sentiment with $34.3M in net insider flow. The most recent transaction on Dec 30, 2022 involved a sale of 15,220 shares valued at $4.1K.
No significant insider buying has been recorded for ONCR in the recent period.
No significant insider selling has been recorded for ONCR in the recent period.
Based on recent SEC filings, insider sentiment for ONCR is bullish with an Insider Alignment Score of 97/100 and a net flow of $34.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Oncorus, Inc. (ONCR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading ONCR stock, having executed 85 transactions in the past 90 days. The most active insider is Healthcare Innovations Fund, L.p. Deerfield (Executive), who has made 17 transactions totaling $15.0M.
Get notified when executives and directors at ONCR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 30, 2022 | E. Flynn James | Executive | Sale | 15,220 | $0.27 | $4.1K | |
| Dec 30, 2022 | E. Flynn James | Executive | Sale | 61,826 | $0.27 | $16.7K | |
| Dec 30, 2022 | E. Flynn James | Executive | Sale | 61,826 | $0.27 | $16.7K | |
| Dec 29, 2022 | E. Flynn James | Executive | Sale | 63,107 | $0.26 | $16.4K | |
| Dec 29, 2022 | E. Flynn James | Executive | Sale | 63,108 | $0.26 | $16.4K | |
| Dec 29, 2022 | E. Flynn James | Executive | Sale | 15,538 | $0.26 | $4.0K | |
| Dec 28, 2022 | E. Flynn James | Executive | Sale | 24,757 | $0.25 | $6.2K | |
| Dec 28, 2022 | E. Flynn James | Executive | Sale | 6,096 | $0.25 | $1.5K | |
| Dec 28, 2022 | E. Flynn James | Executive | Sale | 24,757 | $0.25 | $6.2K | |
| Dec 27, 2022 | Hif, L.p. Deerfield Mgmt | Executive | Sale | 7,136 | $0.27 | $1.9K | |
| Dec 27, 2022 | Hif, L.p. Deerfield Mgmt | Executive | Sale | 28,977 | $0.27 | $7.8K | |
| Dec 27, 2022 | Hif, L.p. Deerfield Mgmt | Executive | Sale | 28,977 | $0.27 | $7.8K | |
| Dec 22, 2022 | Hif, L.p. Deerfield Mgmt | Executive | Sale | 3,693 | $0.28 | $1.0K | |
| Dec 22, 2022 | Hif, L.p. Deerfield Mgmt | Executive | Sale | 3,692 | $0.28 | $1.0K | |
| Dec 22, 2022 | Hif, L.p. Deerfield Mgmt | Executive | Sale | 909 | $0.28 | $255 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 21 | $35.6M | 95.9% |
Sale(S) | 41 | $1.3M | 3.4% |
Exercise(M) | 5 | $230.7K | 0.6% |
Conversion(C) | 18 | $0 | 0.0% |
Insiders at Oncorus, Inc. are accumulating shares at an accelerated pace. With 13 insiders making 85 transactions totaling $35.6M in purchases versus $1.3M in sales, the net buying activity of $34.3M signals strong executive confidence. Healthcare Innovations Fund, L.p. Deerfield (Executive) leads the buying activity with $15.0M in transactions across all time.